(Q40929646)

24 September 2017

Urinary findings and renal function in adult Navajo Indians and associations with type 2 diabetes (English)

1 reference

24 September 2017

Hoy W

1

1 reference

24 September 2017

Jim S

2

1 reference

24 September 2017

Warrington W

3

1 reference

24 September 2017

Light A

4

1 reference

24 September 2017

Megill D

5

1 reference

24 September 2017

language of work or name

1 reference

1 September 1996

1 reference

American Journal of Kidney Diseases

24 September 2017

1 reference

24 September 2017

28

1 reference

24 September 2017

3

1 reference

24 September 2017

339-349

1 reference

Mesangial proliferative glomerulonephritis in southwestern American Indians

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Prevalence of obesity in American Indians and Alaska Natives

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Blood pressure survey on the Navajo Indian reservation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Prevalence of Diabetes and Impaired Glucose Tolerance Among Navajo Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Single-void urine samples can be used to estimate quantitative microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Blood Pressure in Navajo Indians and Its Association With Type 2 Diabetes and Renal and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

A clinical-histological study of individuals with diabetes mellitus and proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

End-stage renal disease attributable to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Prevalence of diagnosed hypertension among diabetic Navajo Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Diabetes mellitus and macrovascular complications. An epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Cardiovascular disease and hypertension in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

A two-step model for development of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990490-4

7 January 2021

10.1016/S0272-6386(96)90490-4

Identifiers

DOI

1 reference

24 September 2017

1 reference